MISC - Cholinergic and Adrenergic Receptors

Question 1

Contraction of most smooth muscles (Adrenoreceptor type)

Answer 1

α1

Question 2

Dilation of pupils (Adrenoreceptor type)

Answer 2

α1

Question 3

Erection of hair/Goosebumps (Adrenoreceptor type)

Answer 3

α1

Question 4

Contraction of prostate (Adrenoreceptor type)

Answer 4

α1

Question 5

Inotropic effect (Increased force of contraction in heart) (Adrenoreceptor type)

Answer 5

α1

Question 6

Aggregation of platelets (Adrenoreceptor type)

Answer 6

α2

Question 7

Inhibition of transmitter release (Adrenoreceptor type)

Answer 7

α2

Question 8

Contraction of some smooth muscles (Adrenoreceptor type)

Answer 8

α2

Question 9

Inhibition of lipolysis (breakdown of fats) (Adrenoreceptor type)

Answer 9

α2

Question 10

Increased force and rate of contraction in heart and juxtaglomerular cells (Adrenoreceptor type)

Answer 10

β1

Question 11

Increased renin release (Adrenoreceptor type)

Answer 11

β1

Question 12

Promotes smooth muscle relaxation of the respiratory, uterine, and vascular smooth muscles (Adrenoreceptor type)

Answer 12

β2

Question 13

Promotes potassium uptake in the skeletal muscle (Adrenoreceptor type)

Answer 13

β2

Question 14

Activates glycogenolysis in the liver (Adrenoreceptor type)

Answer 14

β2

Question 15

Relaxes the detrusor muscle in the bladder (Adrenoreceptor type)

Answer 15

β3

Question 16

Activates lipolysis (breakdown of fats) (Adrenoreceptor type)

Answer 16

β3

Question 17

Dilation of renal blood vessels (Adrenoreceptor type)

Answer 17

D1

Question 18

Modulate transmitter release in nerve endings (Adrenoreceptor type)

Answer 18

D2

Question 19

Positive inotropic and chronotropic effect is via the __________ receptor (Adrenoreceptor type)

Answer 19

β1

Question 19

Vasoconstriction in most blood vessels is via the __________ receptor (Adrenoreceptor type)

Answer 19

α1

Question 20

Vasodilation in some blood vessels is via the __________ receptor (Adrenoreceptor type)

Answer 20

β2

Question 21

Bronchodilation is via the __________ receptor (Adrenoreceptor type)

Answer 21

β2

Question 22

Inhibition of insulin secretion is via the __________ receptor (Adrenoreceptor type)

Answer 22

α2

Question 23

Promotion of insulin secretion is via the __________ receptor (Adrenoreceptor type)

Answer 23

β2

Question 24

Promotion of glucagon secretion is via the __________ receptor (Adrenoreceptor type)

Answer 24

β2

Question 25

Glycogenolysis is via the __________ and __________ receptor (Adrenoreceptor type)

Answer 25

α1, β2

Question 26

Lipolysis is via the __________ receptor (Adrenoreceptor type)

Answer 26

β3

Question 27

Alzheimer’s disease, Cognitive dysfunction, Schizophrenia (Cholinergic receptor type)

Answer 27

M1

Question 28

Alzheimer’s disease, Cognitive dysfunction, Pain (Cholinergic receptor type)

Answer 28

M2

Question 29

COPD, Urinary incontinence, IBD (Cholinergic receptor type)

Answer 29

M3

Question 30

Parkinson’s disease, Schizophrenia, Neuropathic pain (Cholinergic receptor type)

Answer 30

M4

Question 31

Drug dependence, Parkinson’s disease, Schizophrenia (Cholinergic receptor type)

Answer 31

M5

Question 32

Miosis (pupil contraction) is via the __________ receptor (Cholinergic receptor type)

Answer 32

M3

Question 33

Sweating is via the __________ receptor (Cholinergic receptor type)

Answer 33

M3

Question 34

Smooth muscle bronchoconstriction is via the __________ receptor (Cholinergic receptor type)

Answer 34

M3

Question 35

Mad hatter symptom is via the __________ receptor (Cholinergic receptor type)

Answer 35

Nicotinic

Question 37

Hypotension due to higher doses of oxymetazoline, naphazoline, and xylometazoline is via the __________ receptor

Answer 37

α2

Question 38

Phentolamine and phenoxybenzamine decrease TPR via __________ antagonism

Answer 38

α1

Question 39

β antagonists lead to negative inotropic and chronotropic effect via __________ antagonism

Answer 39

β1

Question 40

β antagonists lead to decreased renin secretion by juxtaglomerular cells via __________ antagonism

Answer 40

β1